Webinars hosted or supported by the Skin Cancer Education & Research Foundation



You have questions about skin cancer? We have answers. Enjoy on-demand content or participate in a live question-and-answer session with top experts in the field of dermatology and oncology.

Register Now!

Skin Cancer: Ask the Experts – Live Q/A

June 11, 2021 10:00 AM Pacific Time

In this live ½ hour Q/A session, John A. Carucci, MD, PhD, Dermatologic Surgeon at NYU Langone Health, and Anna Pavlick, DO, Medical Oncologist at Weill Cornell Medicine, answer your questions about the management of nonmelanoma skin cancers.

Frequently Asked Questions in Skin Cancer

In this archived section, Dr John A. Carucci, MD, PhD, Dermatologic Surgeon at NYU Langone Health, and Anna Pavlick, DO, Medical Oncologist at Weill Cornell Medicine, answer questions posed by patients about the management of nonmelanoma skin cancers. You can view the entire below.

You can access the video below. Once you enter the video, please enter your first name, last name, and email. Once we have your information, we will be able to send you a notification when the Q/A session is scheduled.


Webinar Faculty

John A. Carucci, MD, PhD

Dr Carucci is a professor in the Ronald O. Perelman Department of Dermatology at New York University Grossman School of Medicine and Director of Dermatologic Surgery at NYU Langone Health, New York, NY.  He received both his medical degree and his PhD from SUNY Downstate College of Medicine, Brooklyn, NY. He completed his dermatology residency at NYU, after which he pursued a fellowship in dermatologic surgery at Yale–New Haven Medical Center. He currently serves as President of the International Immunosuppression & Transplant Skin Cancer Collaborative. Dr Carucci specializes in reconstructive  surgery using Mohs and laser techniques, particularly for those diagnosed with squamous cell carcinoma. His most recent research has focused on the interaction of the immune system with skin cancers, specifically the role of interleukin-22–producing cells in promoting the development of squamous cell carcinoma. Further research holds the possibility of identifying practical regulatory targets within the IL-22 pathway that could ultimately lead to strategies for blocking tumor development. In addition, Dr Carucci and his collaborators have developed a method of correlating gene expression with the clinical course of squamous cell carcinoma.

Anna Pavlick, BSN, MSc, DO, MBA

Anna Pavlick, BSN, MSc, DO, MBA, is a medical oncologist with more than 20 years of experience treating patients with skin cancer, including basal cell and squamous cell carcinoma, melanoma, and Merkel cell carcinoma. She is also an expert in treating ocular melanoma, eyelid tumors, and other rare solid tumor malignancies. Dr Pavlick earned her medical degree from the University of Medicine and Dentistry of New Jersey (UMDNJ)–Robert Wood Johnson Medical School; her Master of Science in human anatomy from Fairleigh Dickinson University; and her Bachelor of Science in biology and nursing from Fairfield University. She completed an internal medicine residency at UMDNJ and hematology and oncology fellowship training at Memorial Sloan Kettering Cancer Center, after which she joined the faculty of Weill Cornell Medicine, New York, NY, as Professor of Medicine in the Division of Hematology & Medical Oncology. She is the founding Director of the Cutaneous Oncology Program there and at New York-Presbyterian Hospital. Dr Pavlick’s major research interests include investigating targeted therapies, combination therapies, and immunotherapies.

Coming Soon!

Skin Cancer Mythbusters Webinar – with Live Q/A

In this activity, our expert will bust those myths about skin cancer! Stay tuned for the archived and live content.